Related Experiment Video
Updated: Jul 13, 2026

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research
Kevin M Crofton1, John A Foss, Ulla Hass
1Neurotoxicology Division, NHEERL, ORD, US EPA, Research Triangle Park, NC, USA. crofton.kevin@epa.gov
Insights
Positive control studies are essential for reliable developmental neurotoxicity (DNT) risk assessments. This review guides the selection and use of positive control agents to ensure accurate DNT testing and data interpretation.
Area of Science:
- Toxicology
- Neuroscience
- Risk Assessment
Background:
- Developmental neurotoxicity (DNT) testing requires robust positive control data.
- Positive controls validate laboratory performance and the sensitivity of DNT assays.
- These data support the biological significance of findings and confidence in negative results.
Purpose of the Study:
- To provide a practical guide for selecting and using positive control agents in DNT studies.
- To discuss the advantages and disadvantages of various positive control agents for DNT endpoints.
- To offer recommendations for interpreting and reporting positive control data in DNT risk assessments.
Main Methods:
- Review of existing literature on positive control agents in developmental neurotoxicology.
- Analysis of advantages and disadvantages of different positive control agents for specific DNT endpoints.
- Consideration of study design issues pertinent to positive control studies in DNT.
Main Results:
- Positive control data are critical for evaluating laboratory capabilities in DNT testing.
- They aid in determining the biological significance of observed effects and increase confidence in negative findings.
- The review discusses agent selection based on DNT study endpoints and provides guidance on data interpretation.
Conclusions:
- Positive control studies are an integral part of DNT testing and risk assessment.
- Implementing standardized positive control studies enhances the reliability and validity of DNT data.
- Laboratories generating data for risk decisions should incorporate positive control studies into their DNT testing protocols.
Abstract:
Developmental neurotoxicity testing involves functional and neurohistological assessments in offspring during and following maternal and/or neonatal exposure. Data from positive control studies are an integral component in developmental neurotoxicity risk assessments. Positive control data are crucial for evaluating a laboratory's capability to detect chemical-induced changes in measured endpoints. Positive control data are also valuable in a weight-of-evidence approach to help determine the biological significance of results and provide confidence in negative results from developmental neurotoxicity (DNT) studies. This review is a practical guide for the selection and use of positive control agents in developmental neurotoxicology. The advantages and disadvantages of various positive control agents are discussed for the endpoints in developmental neurotoxicity studies. Design issues specific to positive control studies in developmental neurotoxicity are considered and recommendations on how to interpret and report positive control data are made. Positive control studies should be conducted as an integral component of the incorporation and use of developmental neurotoxicity testing methods in laboratories that generate data used in risk decisions.
Related Concept Videos
Toxicity Testing in Animals
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
